December 21, 2016 — KEI has filed comments with the U.S. Army Medical Research and Materiel Command (USAMRMC) on the proposed grant of an exclusive license to Sanofi on patents on a vaccine for Zika Virus.
The Colombian Ministry of Health has finalized the price reduction of Glivec, Novartis’s +$47 billion leukemia drug, with a decrease in price from 368 pesos per milligram to 206.42 pesos per mg.
On Thursday, 15 December 2016, South Africa delivered this poignant, closing statement at WIPO’s Standing Committee on the Law of Patents (SCP). Negotiations broke down on the issue of future work, as the European Union and Group B refused to permit discussions of the Report of the UN Secretary-General’s High-Level Panel on Access to Medicines at future sessions of the SCP.
According to the WIPO website,
Matt Richtel and Andrew Pollack explore the complex policy issues involved with the pricing of products based on taxpayer-funded inventions and research in a front page New York Times story published today.
In November, NIST proposed to amend the regulations implementing the Bayh-Dole Act, 35 U.S.C. 200 et seq., which concerns intellectual property arising from federally-funded research, including 37 CFR sections 401 and 404. There were 15 comments, including a letter from KEI on December 9, 2016. EFF also provided comments. The other 13 comments to NIST were from Universities, associations or individuals taking the side of right-holders.
The KEI comments are available here.
On Wednesday, 14 December 2016, the delegation of South Africa delivered a comprehensive, moving account of South Africa’s “journey in the quest to provide access to essential medicines” at WIPO’s Standing Committee on the Law of Patents.
South Africa Access to Medicines: South Africa’s Experience Related to the Topic of Access to Medicines at the Standing Committee on the Laws of PatentsBackground
Madam Vice Chair,
PCB39: Address of Justice Michael Kirby – HIV/AIDS & Solidarity – 30 Years On
On 7 December 2016, Justice Michael Kirby delivered the following keynote speech at the 39th Meeting of the UNAIDS Programme Coordinating Board during discussions on intellectual property and access to medicines. Justice Kirby served as a member of the United Nations Secretary-General’s High-Level Panel on Access to Medicines.
UNAIDS
PROGRAMME COORDINATING BOARD
39TH MEETING, WHO, GENEVA
AGENDA ITEM 6, 7 DECEMBER 2016HIV/AIDS & SOLIDARITY – 30 YEARS ON*
Michael Kirby**
SCP25: Statement of Asia Pacific Group on Patents and Health
On Tuesday, 13 December 2016, India delivered the following statement on behalf of the Asia and the Pacific Group during WIPO discussions on patents and health.
Statement by India on behalf of the Asia and the Pacific Group on the Agenda Item – Patents and Health – delivered by Dr. Sumit Seth, First Secretary (Economic Affairs) on 13 December 2016Madam Chair,
India has the honour to deliver this statement on behalf of the Asia Pacific Group. The group would like to make 3 concrete points related to this agenda item